Tarsus Pharmaceuticals
The role focuses on developing clinical strategies for assigned programs, authoring trial protocols, and ensuring efficient execution of clinical development plans across therapeutic areas such as eye care and dermatology. The scientist will collaborate with cross‑functional teams, manage study documentation, and serve as a primary point of contact for site and CRO inquiries while supporting regulatory interactions and scientific communications.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
24% above the average for this role